"Drug Evaluation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.
Descriptor ID |
D004341
|
MeSH Number(s) |
E05.337.425
|
Concept/Terms |
Drug Evaluation- Drug Evaluation
- Drug Evaluations
- Evaluation, Drug
- Evaluations, Drug
- Evaluation Studies, Drug
- Drug Evaluation Studies
- Drug Evaluation Study
- Evaluation Study, Drug
- Studies, Drug Evaluation
- Study, Drug Evaluation
|
Below are MeSH descriptors whose meaning is more general than "Drug Evaluation".
Below are MeSH descriptors whose meaning is more specific than "Drug Evaluation".
This graph shows the total number of publications written about "Drug Evaluation" by people in this website by year, and whether "Drug Evaluation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 0 | 2 |
2002 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2010 | 0 | 2 | 2 |
2011 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Evaluation" by people in Profiles.
-
Garmendia CA, Nassar Gorra L, Rodriguez AL, Trepka MJ, Veledar E, Madhivanan P. Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials. JAMA Intern Med. 2019 04 01; 179(4):582-584.
-
Han J, Saraf SL, Molokie RE, Gordeuk VR. Use of metformin in patients with sickle cell disease. Am J Hematol. 2019 01; 94(1):E13-E15.
-
Eko FO, Okenu DN, Singh UP, He Q, Black C, Igietseme JU. Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate. Vaccine. 2011 May 12; 29(21):3802-10.
-
Li G, Simon MJ, Cancel LM, Shi ZD, Ji X, Tarbell JM, Morrison B, Fu BM. Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies. Ann Biomed Eng. 2010 Aug; 38(8):2499-511.
-
Bingham JP, Mitsunaga E, Bergeron ZL. Drugs from slugs--past, present and future perspectives of omega-conotoxin research. Chem Biol Interact. 2010 Jan 05; 183(1):1-18.
-
Corey S. Recent developments in the therapeutic potential of cannabinoids. P R Health Sci J. 2005 Mar; 24(1):19-26.
-
Gifford AL, Cunningham WE, Heslin KC, Andersen RM, Nakazono T, Lieu DK, Shapiro MF, Bozzette SA. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002 May 02; 346(18):1373-82.
-
Kusek JW, Lee JY, Charleston J, Faulkner M, Levell B, Milligan S, Norris K. Participant satisfaction in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996 Aug; 17(4 Suppl):47S-54S.
-
Whelton PK, Lee JY, Kusek JW, Charleston J, DeBruge J, Douglas M, Faulkner M, Greene PG, Jones CA, Kiefer S, Kirk KA, Levell B, Norris K, Powers SN, Retta TM, Smith DE, Ward H. Recruitment experience in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996 Aug; 17(4 Suppl):17S-33S.
-
Santiago-Borrero PJ, Casanova R. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP). Bol Asoc Med P R. 1990 May; 82(5):207-10.